shortagewatch

Home / Systemic hormones / Methylprednisolone

ATC H02AB04 · Glucocorticoids

Methylprednisolone shortage

As of 2 Nov 2026, Methylprednisolone has a reported shortage in 8 of the 16 countries we track (United States, Canada, Germany, Italy, Spain, Austria, Belgium, Japan), covering 27 products from 6 companies.

Countries8/16
Products27packs or presentations
Companies62 listed
Short since29 Feb 201610.7 years ago
Earliest return30 Nov 2026company estimate
Main reasonIncreased demand
United States1 product shortCanada2 products shortGermany11 products shortFranceNo reported shortageItaly5 products shortSpain4 products shortIrelandNo reported shortageAustria1 product shortBelgium1 product shortSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapan2 products shortNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

United StatesCanadaGermanyItalySpainAustriaBelgiumJapan
202220232024202520262028Methylprednisolone Acetate, Injection, 80 mgMethylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01)METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJEMETHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION (10)MEDROL (1x100 PBTL)MEDROL (1x100 PBTL)Urbason solubile forte 1000 mgUrbason solubile forte 1000 mgUrbason solubile forte 1000 mgUrbason solubile forte 1000 mgUrbason solubile forte 250 mgUrbason solubile forte 250 mgUrbason solubile forte 250 mgUrbason solubile forte 250 mgUrbason solubile forte 250 mgUrbason solubile forte 250 mgMetypred 125mg GALENMetypred 125mg GALENMetypred 250mg GALENMetypred 250mg GALENMetypred 250mg GALENMetypred 250mg GALENMetypred forte 1000mg GALENMetypred forte 1000mg GALENMetypred forte 1000mg GALENMetypred forte 1000mg GALENMetypred forte 1000mg GALENMetypred forte 1000mg GALENURBASON SOLUBILEURBASON SOLUBILEURBASON SOLUBILEURBASON SOLUBILEDEPO MEDROLDEPO MEDROLLISAMETHYLELISAMETHYLELISAMETHYLELISAMETHYLEURBASON 250 mg POLVO Y DISOLVENTE PARA SOLUCURBASON 250 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE O PARA PERFUSION, 50 ampollas + 50 ampollas de disolventeURBASON 250 mg POLVO Y DISOLVENTE PARA SOLUCURBASON 250 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE O PARA PERFUSION, 1 ampolla + 1 ampolla de disolventeSOLU-MODERIN 125 MG POLVO Y DISOLVENTE PARA SOLU-MODERIN 125 MG POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE , 50 viales + 50 ampollas de disolventeSOLU-MODERIN 125 MG POLVO Y DISOLVENTE PARA SOLU-MODERIN 125 MG POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE , 3 viales + 3 ampollas de disolventeUrbason solubile 250 mg Trockenampullen mit Urbason solubile 250 mg Trockenampullen mit Lösungsmittel, 5 StückMedrol A 16 mg tabl. 50Medrol A 16 mg tabl. 50デポ・メドロール水懸注20mgデポ・メドロール水懸注20mgデポ・メドロール水懸注40mgデポ・メドロール水懸注40mgtoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Fidia10Pfizer7 PFEGalenpharma6Italiano Biochimico2Par1Teva1 TEVA

Listed: Teva TEVA · NYSE / TASE, Pfizer PFE · NYSE

Compared with similar medicines

ATC group H02AB · Glucocorticoids
Dexamethasone10/16Methylprednisolone8/16Triamcinolone8/16Betamethasone7/16Hydrocortisone4/16Prednisolone2/16Deflazacort1/16Prednisone1/16

Affected products

CountryProductCompanySinceExpected backReason
USMethylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01)Par Health, USA LLC16 Jun 2022not givenOther
CAMETHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION (10)TEVA CANADA LIMITED29 Feb 2016not givenManufacturing problem
Disruption of the manufacture of the drug
CAMEDROL (1x100 PBTL)PFIZER CANADA ULC21 Oct 202630 Nov 2026Manufacturing problem
Disruption of the manufacture of the drug
DEUrbason solubile forte 1000 mgFIDIA FARMACEUTICI SPA31 Mar 202530 Jun 2027Increased demand
Erhöhte Nachfrage
DEUrbason solubile forte 1000 mgFIDIA FARMACEUTICI SPA31 Mar 202530 Jun 2027Increased demand
Erhöhte Nachfrage
DEUrbason solubile forte 250 mgFIDIA FARMACEUTICI SPA14 Apr 202531 Dec 2026Increased demand
Erhöhte Nachfrage
DEUrbason solubile forte 250 mgFIDIA FARMACEUTICI SPA14 Apr 202531 Dec 2026Increased demand
Erhöhte Nachfrage
DEUrbason solubile forte 250 mgFIDIA FARMACEUTICI SPA14 Apr 202531 Dec 2026Increased demand
Erhöhte Nachfrage
DEMetypred 125mg GALENGALENpharma GmbH1 May 202531 Dec 2026Other
Sonstige
DEMetypred 250mg GALENGALENpharma GmbH1 May 202531 Dec 2026Other
Sonstige
DEMetypred 250mg GALENGALENpharma GmbH1 May 202531 Dec 2026Other
Sonstige
DEMetypred forte 1000mg GALENGALENpharma GmbH1 May 202531 Dec 2026Other
Sonstige
DEMetypred forte 1000mg GALENGALENpharma GmbH1 May 202531 Dec 2026Other
Sonstige
DEMetypred forte 1000mg GALENGALENpharma GmbH1 May 202531 Dec 2026Other
Sonstige
ITURBASON SOLUBILEFIDIA FARMACEUTICI S.P.A.25 Nov 2024not givenManufacturing problem
Problemi produttivi
ITURBASON SOLUBILEFIDIA FARMACEUTICI S.P.A.29 Nov 2024not givenManufacturing problem
Problemi produttivi (carenza relativa solo al canale ospedaliero)
ITDEPO MEDROL discontinuationPFIZER ITALIA S.R.L.11 Sep 2025not givenIncreased demand
Elevata richiesta: forniture discontinue
ITLISAMETHYLELABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA S.P.A.25 Oct 2025not givenCommercial decision or withdrawal
Motivi commerciali
ITLISAMETHYLELABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA S.P.A.25 Oct 2025not givenManufacturing problem
Problemi produttivi
ESURBASON 250 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE O PARA PERFUSION, 50 ampollas + 50 ampollas de disolventeFidia Farmaceutici S.P.A.13 Jun 202430 Dec 2026Not stated
ESURBASON 250 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE O PARA PERFUSION, 1 ampolla + 1 ampolla de disolventeFidia Farmaceutici S.P.A.18 Sep 202530 Dec 2026Not stated
ESSOLU-MODERIN 125 MG POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE , 50 viales + 50 ampollas de disolventePfizer S.L.16 Jul 202629 Apr 2027Not stated
ESSOLU-MODERIN 125 MG POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE , 3 viales + 3 ampollas de disolventePfizer S.L.15 Oct 202629 Apr 2027Not stated
ATUrbason solubile 250 mg Trockenampullen mit Lösungsmittel, 5 StückFidia Farmaceutici S.p.A.1 Jan 202631 May 2027Manufacturing problem
Produktionstransfer zu einem alternativen Hersteller
BEMedrol A 16 mg tabl. 50Pfizer21 Sep 202611 Dec 2026Manufacturing problem
Delay in production
デポ・メドロール水懸注20mg limitedファイザー12 Jun 2025not givenIncreased demand
デポ・メドロール水懸注40mg limitedファイザー12 Jun 2025not givenIncreased demand

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.